<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1768652" created="06/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1768652</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="kappa_B-specific_DNA_binding_protein" sem="Protein_family_or_group"><term id="A101" sem="DNA_domain_or_region">Kappa B</term>-specific DNA binding <term id="A102" sem="Protein_family_or_group">proteins</term></term> are differentially inhibited by <term id="T2" lex="enhancer_mutation" sem="Other"><term id="A1" sem="DNA_domain_or_region">enhancer</term> mutations</term> and <term id="T3" lex="biological_oxidation" sem="Other">biological oxidation</term>.</sentence>
<event id="E1">
<type class="Mutagenesis"/>
<theme idref="A1"/>
<clue>Kappa B-specific DNA binding proteins are differentially inhibited by enhancer <clueType>mutations</clueType> and biological oxidation.</clue>
<comment>ARTIFICIAL</comment></event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="T1"/>
<cause idref="E1"/>
<clue>Kappa B-specific DNA binding proteins are differentially <clueType>inhibited</clueType> <linkCause>by</linkCause> enhancer mutations and biological oxidation.</clue>
</event>
<event id="E3">
<type class="Negative_regulation"/>
<theme idref="T1"/>
<cause idref="T3"/>
<clue>Kappa B-specific DNA binding proteins are differentially <clueType>inhibited</clueType> <linkCause>by</linkCause> enhancer mutations and biological oxidation.</clue>
</event>
<event KT="Other" id="E101">
<type class="Binding"/>
<theme idref="A101"/>
<theme idref="A102"/>
<clue>Kappa B-<linkTheme>specific</linkTheme> DNA <clueType>binding</clueType> proteins are differentially inhibited by enhancer mutations and biological oxidation.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T4" lex="kappa_B_(kappa_B)_enhancer_binding_protein" sem="Protein_family_or_group"><term id="A103" sem="DNA_domain_or_region">Kappa B (kappa B) enhancer</term> binding <term id="A104" sem="Protein_family_or_group">proteins</term></term> isolated from the nuclei of activated <term id="T5" lex="human_T_cell" sem="Cell_natural">human T cells</term> produce two distinct <term id="T6" lex="nucleoprotein_complex" sem="Protein_complex">nucleoprotein complexes</term> when incubated with the <term id="T7" lex="kappa_B_element" sem="DNA_domain_or_region">kappa B element</term> from the <term id="T8" lex="interleukin-2_receptor-alpha_(IL-2R_alpha)_gene" sem="DNA_domain_or_region">interleukin-2 receptor-alpha (<term id="T9" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term>) gene</term>.</sentence>
<event KT="Fact" id="E4">
<type class="Binding"/>
<theme idref="T4"/>
<theme idref="T7"/>
<clue>Kappa B (kappa B) enhancer binding proteins isolated from the nuclei of activated human T cells <clueType>produce</clueType> two distinct nucleoprotein <clueType>complexes</clueType> <linkTheme>when incubated with</linkTheme> the kappa B element from the interleukin-2 receptor-alpha (IL-2R alpha) gene.</clue>
</event>
<event KT="Other" id="E102">
<type class="Binding"/>
<theme idref="A103"/>
<theme idref="A104"/>
<clue>Kappa B (kappa B) enhancer <clueType>binding</clueType> proteins isolated from the nuclei of activated human T cells produce two distinct nucleoprotein complexes when incubated with the kappa B element from the interleukin-2 receptor-alpha (IL-2R alpha) gene.</clue>
</event>
<sentence id="S3">These two <term id="T10" lex="DNA-protein_complex" sem="Protein_complex">DNA-protein complexes</term> are composed of at least four host proteins (<term id="T11" lex="p50" sem="Protein_molecule">p50</term>, <term id="T12" lex="p55" sem="Protein_molecule">p55</term>, <term id="T13" lex="p75" sem="Protein_molecule">p75</term>, <term id="T14" lex="p85" sem="Protein_molecule">p85</term>), each of which shares structural similarity with the <term id="T15" lex="v-rel_oncogene_product" sem="Protein_molecule">v-rel oncogene product</term>.</sentence>
<sentence id="S4"><term id="T16" lex="nuclear_expression" sem="Other">Nuclear expression</term> of these proteins is induced with distinctly <term id="T17" lex="biphasic_kinetics" sem="Other">biphasic kinetics</term> following <term id="T18" lex="phorbol_ester" sem="Organic_compound_other">phorbol ester</term> activation of <term id="T19" lex="T_cell" sem="Cell_natural">T cells</term> (<term id="T20" lex="p55/p75_early" sem="Protein_molecule">p55/p75 early</term> and <term id="T21" lex="p50/p85_late" sem="Protein_molecule">p50/p85 late</term>).</sentence>
<event KT="Other" id="E6">
<type class="Physiological_process"/>
<theme idref="T19"/>
<cause idref="T18"/>
<clue>Nuclear expression of these proteins is induced with distinctly biphasic kinetics following phorbol ester <clueType>activation</clueType> <linkTheme>of</linkTheme> T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T11"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Other" id="E8">
<type class="Gene_expression"/>
<theme idref="T12"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>these proteins</corefTheme> is induced with distinctly biphasic kinetics following phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="E6"/>
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E6"/>
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Fact" id="E13">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E6"/>
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<event KT="Fact" id="E14">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E6"/>
<clue>Nuclear expression of these proteins is <clueType>induced</clueType> with distinctly biphasic kinetics <linkCause>following</linkCause> phorbol ester activation of T cells (p55/p75 early and p50/p85 late).</clue>
</event>
<sentence id="S5"><term id="T22" lex="DNA-protein_crosslinking_study" sem="Other">DNA-protein crosslinking studies</term> have revealed that the more rapidly migrating <term id="T23" lex="B2_complex" sem="Protein_complex">B2 complex</term> contains both <term id="T24" lex="p50" sem="Protein_molecule">p50</term> and <term id="T25" lex="p55" sem="Protein_molecule">p55</term> while the more slowly migrating <term id="T26" lex="B1_complex" sem="Protein_complex">B1 complex</term> is composed of <term id="T27" lex="p50" sem="Protein_molecule">p50</term>, <term id="T28" lex="p55" sem="Protein_molecule">p55</term>, <term id="T29" lex="p75" sem="Protein_molecule">p75</term>, and <term id="T30" lex="p85" sem="Protein_molecule">p85</term>.</sentence>
<event Manner="High" id="E103">
<type class="Localization"/>
<theme idref="T23"/>
<clue>DNA-protein crosslinking studies have revealed that the more <clueTime><clueManner>rapidly</clueManner></clueTime> <clueType>migrating</clueType> B2 complex contains both p50 and p55 while the more slowly migrating B1 complex is composed of p50, p55, p75, and p85.</clue>
</event>
<event Manner="Low" id="E104">
<type class="Localization"/>
<theme idref="T26"/>
<clue>DNA-protein crosslinking studies have revealed that the more rapidly migrating B2 complex contains both p50 and p55 while the more <clueTime><clueManner>slowly</clueManner></clueTime> <clueType>migrating</clueType> B1 complex is composed of p50, p55, p75, and p85.</clue>
</event>
<sentence id="S6">Site-directed mutagenesis of the <term id="T31" lex="wild-type_IL-2R_alpha_kappa_B_enhancer" sem="DNA_domain_or_region">wild-type IL-2R alpha kappa B enhancer</term> (<term id="T32" lex="GGGGAATCTCCC" sem="Polynucleotide">GGGGAATCTCCC</term>) has revealed that the binding of <term id="T33" lex="p50" sem="Protein_substructure">p50</term> and <term id="T34" lex="p55" sem="Protein_molecule">p55</term> (<term id="T35" lex="B2_complex" sem="Protein_complex">B2 complex</term>) is particularly sensitive to alteration of the <term id="A111" sem="DNA_domain_or_region"><term id="T36" lex="5&apos;_triplet" sem="DNA_domain_or_region">5&apos; triplet</term> of <term id="T37" lex="deoxyguanosine_residue" sem="Nucleotide">deoxyguanosine residues</term></term>.</sentence>
<event KT="Other" id="E18">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="T31"/>
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the <clueType>binding</clueType> of p50 and p55 (B2 complex) is particularly sensitive to alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>Ner T33 mod</comment></event>
<event KT="Other" id="E19">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="T31"/>
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the <clueType>binding</clueType> of p50 and p55 (B2 complex) is particularly sensitive to alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
</event>
<event KT="Method" id="E105">
<type class="Mutagenesis"/>
<theme idref="A111"/>
<clue>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC) has revealed that the binding of p50 and p55 (B2 complex) is particularly sensitive to <clueType>alteration</clueType> <linkTheme>of</linkTheme> the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>TPS A111, ARTIFICIAL</comment></event>
<event KT="Analysis" id="E20">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="E105"/>
<clue><clueExperiment>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC)</clueExperiment> has <clueKT>revealed</clueKT> that the binding of p50 and p55 (B2 complex) is particularly <clueType>sensitive</clueType> <linkCause>to</linkCause> alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Analysis" id="E157">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="E105"/>
<clue><clueExperiment>Site-directed mutagenesis of the wild-type IL-2R alpha kappa B enhancer (GGGGAATCTCCC)</clueExperiment> has <clueKT>revealed</clueKT> that the binding of p50 and p55 (B2 complex) is particularly <clueType>sensitive</clueType> <linkCause>to</linkCause> alteration of the 5&apos; triplet of deoxyguanosine residues.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S7">In contrast, formation of the <term id="T38" lex="B1_complex" sem="Protein_complex">B1 complex</term>, reflecting the binding of <term id="T39" lex="p75" sem="Protein_molecule">p75</term> and <term id="T40" lex="p85" sem="Protein_molecule">p85</term>, critically depends upon the more <term id="A2" sem="DNA_domain_or_region">3&apos; sequences of this <term id="T41" lex="enhancer_element" sem="DNA_domain_or_region">enhancer element</term>.</term></sentence>
<event CL="L2" KT="Analysis" id="E21">
<type class="Binding"/>
<theme idref="T39"/>
<theme idref="T31"/>
<clue>In contrast, formation of the B1 complex, <clueKT><clueCL>reflecting</clueCL></clueKT> the <clueType>binding</clueType> <linkTheme>of</linkTheme> p75 and p85, critically depends upon the more 3&apos; sequences of <corefTheme>this enhancer element</corefTheme>.</clue>
<comment>TPS A2</comment></event>
<event CL="L2" KT="Analysis" id="E56">
<type class="Binding"/>
<theme idref="T40"/>
<theme idref="T31"/>
<clue>In contrast, formation of the B1 complex, <clueKT><clueCL>reflecting</clueCL></clueKT> the <clueType>binding</clueType> <linkTheme>of</linkTheme> p75 and p85, critically depends upon the more 3&apos; sequences of <corefTheme>this enhancer element</corefTheme>.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="A2"/>
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E257">
<type class="Binding"/>
<theme idref="T38"/>
<clue>In contrast, <clueType>formation</clueType> <linkTheme>of</linkTheme> the B1 <clueType>complex</clueType>, reflecting the binding of p75 and p85, critically depends upon the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E258">
<type class="Positive_regulation"/>
<theme idref="E56"/>
<cause idref="A2"/>
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<event id="E259">
<type class="Positive_regulation"/>
<theme idref="E257"/>
<cause idref="A2"/>
<clue>In contrast, formation of the B1 complex, reflecting the binding of p75 and p85, critically <clueType>depends</clueType> <linkCause>upon</linkCause> the more 3&apos; sequences of this enhancer element.</clue>
</event>
<sentence id="S8"><term id="A3" sem="DNA_domain_or_region">DNA</term> binding by all four of these <term id="T42" lex="Rel-related_factor" sem="Protein_family_or_group">Rel-related factors</term> is blocked by selective chemical modification of <term id="T43" lex="lysine" sem="Amino_acid_monomer">lysine</term> and <term id="T44" lex="arginine_residue" sem="Amino_acid_monomer">arginine</term> residues, suggesting that both of these <term id="T45" lex="basic_amino_acid" sem="Amino_acid_monomer">basic amino acids</term> are required for binding to the <term id="T46" lex="kappa_B_element" sem="DNA_domain_or_region">kappa B element</term>.</sentence>
<event KT="Other" id="E23">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="T27"/>
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event KT="Other" id="E24">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="T28"/>
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event KT="Other" id="E25">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="T29"/>
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event KT="Other" id="E26">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="T30"/>
<clue>DNA <clueType>binding</clueType> <linkTheme>by</linkTheme> <corefTheme>all four of these Rel-related factors</corefTheme> is blocked by selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E27">
<type class="Protein_modification"/>
<theme idref="T42"/>
<site idref="T43"/>
<clue>DNA binding by all four of these Rel-related factors is blocked by selective chemical <clueType>modification</clueType> of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E28">
<type class="Protein_modification"/>
<theme idref="T42"/>
<site idref="T44"/>
<clue>DNA binding by all four of these Rel-related factors is blocked by selective chemical <clueType>modification</clueType> of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
<comment>NER T44 mod</comment></event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E27"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E27"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E27"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E27"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E28"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E28"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E28"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E28"/>
<clue>DNA binding by all four of these Rel-related factors is <clueType>blocked</clueType> <linkCause>by</linkCause> selective chemical modification of lysine and arginine residues, suggesting that both of these basic amino acids are required for binding to the kappa B element.</clue>
</event>
<sentence id="S9">Similarly, covalent modification of free <term id="T47" lex="sulfhydryl_group" sem="Organic_compound_other">sulfhydryl groups</term> with <term id="T48" lex="diamide" sem="Organic_compound_other">diamide</term> (reversible) or <term id="T49" lex="N-ethylmaleimide" sem="Organic_compound_other">N-ethylmaleimide</term> (irreversible) results in a complete loss of <term id="T50" lex="DNA_binding_activity" sem="Other">DNA binding activity</term>.</sentence>
<event id="E37">
<type class="Protein_modification"/>
<theme idref="T27"/>
<site idref="T47"/>
<clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E5">
<type class="Protein_modification"/>
<theme idref="T28"/>
<site idref="T47"/>
<clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E15">
<type class="Protein_modification"/>
<theme idref="T29"/>
<site idref="T47"/>
<clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E16">
<type class="Protein_modification"/>
<theme idref="T30"/>
<site idref="T47"/>
<clue>Similarly, covalent <clueType>modification</clueType> of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T48"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T48"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E42">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T48"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T48"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E50">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T49"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E59">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T49"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E60">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T49"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E61">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T49"/>
<clue>Similarly, covalent modification of free sulfhydryl groups <linkCause>with</linkCause> diamide (reversible) or N-ethylmaleimide (irreversible) results in a complete loss of DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event Manner="High" id="E39">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E17"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E40">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E38"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E57">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E41"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E58">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E47"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E62">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E50"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E63">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E59"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E64">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="E60"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<event Manner="High" id="E65">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E61"/>
<clue>Similarly, covalent modification of free sulfhydryl groups with diamide (reversible) or N-ethylmaleimide (irreversible) <clueType>results in</clueType> a <clueManner>complete</clueManner> <clueType>loss</clueType> of <corefTheme>DNA binding activity</corefTheme>.</clue>
</event>
<sentence id="S10">In contrast, mild oxidation with <term id="T51" lex="glucose_oxidase" sem="Protein_molecule">glucose oxidase</term> selectively inhibits <term id="T52" lex="p75" sem="Protein_molecule">p75</term> and <term id="T53" lex="p85" sem="Protein_molecule">p85</term> binding while not blocking <term id="T54" lex="p50" sem="Protein_molecule">p50</term> and <term id="T55" lex="p55" sem="Protein_molecule">p55</term> interactions.</sentence>
<event Manner="Low" id="E41">
<type class="Protein_metabolism"/>
<theme idref="T52"/>
<clue>In contrast, <clueManner>mild</clueManner> <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event Manner="Low" id="E66">
<type class="Protein_metabolism"/>
<theme idref="T53"/>
<clue>In contrast, <clueManner>mild</clueManner> <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event Manner="Low" id="E67">
<type class="Protein_metabolism"/>
<theme idref="T54"/>
<clue>In contrast, <clueManner>mild</clueManner> <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event Manner="Low" id="E68">
<type class="Protein_metabolism"/>
<theme idref="T55"/>
<clue>In contrast, <clueManner>mild</clueManner> <clueType>oxidation</clueType> with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E69">
<type class="Positive_regulation"/>
<theme idref="E41"/>
<cause idref="T51"/>
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E70">
<type class="Positive_regulation"/>
<theme idref="E66"/>
<cause idref="T51"/>
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E71">
<type class="Positive_regulation"/>
<theme idref="E67"/>
<cause idref="T51"/>
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E72">
<type class="Positive_regulation"/>
<theme idref="E68"/>
<cause idref="T51"/>
<clue>In contrast, mild oxidation <linkCause>with</linkCause> glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E43">
<type class="Binding"/>
<theme idref="T52"/>
<theme idref="A3"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 <clueType>binding</clueType> while not blocking p50 and p55 interactions.</clue>
<comment>NO COREFTHEME for A3</comment></event>
<event id="E44">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="E41"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively <clueType>inhibits</clueType> p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event KT="Other" id="E45">
<type class="Binding"/>
<theme idref="T53"/>
<theme idref="A3"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 <clueType>binding</clueType> while not blocking p50 and p55 interactions.</clue>
<comment>NO COREFTHEME for A3</comment></event>
<event id="E46">
<type class="Negative_regulation"/>
<theme idref="E45"/>
<cause idref="E66"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively <clueType>inhibits</clueType> p75 and p85 binding while not blocking p50 and p55 interactions.</clue>
</event>
<event id="E48">
<type class="Binding"/>
<theme idref="T54"/>
<theme idref="A3"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 <clueType>interactions</clueType>.</clue>
<comment>NO COREFTHEME for A3</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E49">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E67"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while <cluePolarity>not</cluePolarity> <clueType>blocking</clueType> p50 and p55 interactions.</clue>
</event>
<event id="E51">
<type class="Binding"/>
<theme idref="T55"/>
<theme idref="A3"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while not blocking p50 and p55 <clueType>interactions</clueType>.</clue>
<comment>NO COREFTHEME for A3</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E52">
<type class="Negative_regulation"/>
<theme idref="E51"/>
<cause idref="E68"/>
<clue>In contrast, mild oxidation with glucose oxidase selectively inhibits p75 and p85 binding while <cluePolarity>not</cluePolarity> <clueType>blocking</clueType> p50 and p55 interactions.</clue>
</event>
<sentence id="S11">These findings suggest that <term id="T56" lex="reduced_cysteine_thiol" sem="Amino_acid_monomer">reduced <term id="A4" sem="Amino_acid_monomer">cysteine</term> thiols</term> play an important role in the <term id="T57" lex="DNA_binding_activity" sem="Other"><term id="A5" sem="DNA_domain_or_region">DNA</term> binding activity</term> of this family of <term id="T58" lex="Rel-related_transcription_factor" sem="Protein_family_or_group">Rel-related transcription factors</term>.</sentence>
<event KT="Other" id="E53">
<type class="Metabolism"/>
<theme idref="A4"/>
<clue>These findings suggest that <clueType>reduced</clueType> cysteine <clueType>thiols</clueType> play an important role in the DNA binding activity of this family of Rel-related transcription factors.</clue>
</event>
<event KT="Other" id="E54">
<type class="Binding"/>
<theme idref="A5"/>
<theme idref="T58"/>
<clue>These findings suggest that reduced cysteine thiols play an important role in the DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> this family of Rel-related transcription factors.</clue>
</event>
<event CL="L2" KT="Analysis" id="E55">
<type class="Regulation"/>
<theme idref="E54"/>
<cause idref="E53"/>
<clue>These findings <clueKT><clueCL>suggest</clueCL></clueKT> that reduced cysteine thiols <clueType>play</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the DNA binding activity of this family of Rel-related transcription factors.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
